Assembly Biosciences Inc (ASMB) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Assembly Biosciences Inc   (NASDAQ: ASMB)


Assembly Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Assembly Biosciences Inc's ROI in the second quarter of 2026?
Assembly Biosciences Inc recorded a cumulative net loss of $0 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -0.02%.

Within the Healthcare sector 120 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2804 to 2816.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 318.46 % 145.46 % 68.78 % 10.42 % -27.38 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 307 201 209 187 33
Return On Investment (TTM) -0.02 % -4.06 % -5.09 % -44.84 % -72.2 %
ASMB's Overall Ranking # 2816 # 2804 # 2587 # 3354 # 3233
Seq. Investment Change TTM 43.52 % 30.78 % 39.97 % 59.29 % -15.82 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 -6 -6 -39 -39




Return On Investment ASMB's Ranking
Within: No.
Industry # 34
Sector # 121
Overall # 2816

Return On Investment Statistics
High Average Low
1.6 %
-52.11 %
-146.69 %
(Dec 31 2014)   (Sep 30 2012)







Financial Statements
Assembly Biosciences Inc's II. Quarter Investments $ 307 Millions ASMB's Balance sheet
Assembly Biosciences Inc's II. Quarter Income $ -4 Millions Quarterly ASMB's Income Statement
ASMB's Income by Division See ASMB's Income by Division


ASMB Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 209 71 98 85 175
Y / Y Investment Growth 192.59 % -26.88 % 14.15 % -51.14 % -32.39 %
Net Income in Millions -6 -40 -61 -93 -130
Y / Y Net Income Growth - - - - -
Annual Return On Investment -2.93 % -56.3 % -62.73 % -108.88 % -74.21 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ASMB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ASMB's Competitors
Subscribers only: Roi for Assembly Biosciences Inc's Suppliers
Subscribers only: Return On Investment for ASMB's Customers

Other Ratios
ASMB's Roa ASMB's Inventory Turnover Ratio ASMB's Growth Rates ASMB's Dividend Statistics
ASMB's Profitability Ratios ASMB's Asset Turnover Ratio ASMB's Dividend Growth
ASMB's Roe ASMB's Valuation Ratios ASMB's Financial Strength Ratios ASMB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-03T11:31:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.